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Controlling the DNA Binding Specificity
of bHLH Proteins
through Intramolecular Interactions
shift assays and isothermal titration calorimetry revealed
that the apparent dissociation constants of complexes
with E-box-containing DNA sequences and of com-
plexes with completely unrelated DNA sequences were
similar [9, 11, 12]. Hence, the specificity of transcrip-
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University of Birmingham tional activation needed to explain the exquisite physio-
logical specificity of MASH-1 and MyoD cannot beEdgbaston
Birmingham, B15 2TT based solely on their intrinsic DNA binding specificities
but might be achieved through cooperative interactionsUnited Kingdom
with other components of the transcriptional machinery
such as myocyte enhancer factors-2 (MEF-2) [13]. While
not intrinsically myo- or neurogenic, the proteins of theSummary
MEF-2 family have been shown to act as coregulators
to potentiate the myogenic and neurogenic effects ofReversible control of the conformation of proteins was
MyoD and MASH-1 [14, 15].employed to probe the relationship between flexibility
The DNA binding reactions of bHLH proteins are char-and specificity of the basic helix-loop-helix protein
acterized by a transition from a largely unfolded to aMyoD. A fusion protein (apaMyoD) was designed
mainly -helical conformation of the bHLH domain [9, 11].where the basic DNA binding helix of MyoD was stab-
The limited DNA binding specificity of bHLH proteinslized by an amino-terminal extension with a sequence
has been postulated to be a consequence of their con-derived from the bee venom peptide apamin. The disul-
formational flexibility due to high solvent accessibilityfide-stabilized helix from apamin served as a nucleus
[16]. Limiting the number of accessible conformationsfor a helix that extended for a further ten residues,
of the residues in the basic region of bHLH proteins, forthereby holding apaMyoD’s DNA recognition helix in
instance, through the interaction with other proteins,a predominantly -helical conformation. The thermal
should increase their DNA binding specificity by stabiliz-stability of the DNA complexes of apaMyoD was in-
ing the interaction with DNA sequences containing thecreased by 13C relative to MyoD-bHLH. Measure-
preferred binding site or destabilizing the complex withments of the fluorescence anisotropy change on DNA
heterologous DNA sequences. Herein we report the con-binding indicated that apaMyoD bound to E-box-con-
struction of a model system for the modulation of thetaining DNA sequences with enhanced affinity relative
DNA binding specificity of bHLH proteins through intra-to MyoD-bHLH. Consequently, the DNA binding speci-
molecular interactions in which the DNA recognition he-ficity of apaMyoD was increased 10-fold.
lix of MyoD was stabilized through an additional N-ter-
minal disulfide-stabilized motif (Figure 1).
Introduction
DNA binding proteins have evolved to deal with a prob- Results
lem not normally encountered by enzymes: namely that
the substrate, which is a specific DNA fragment, is im- Design of ApaMyoD
mersed in a sea of other DNA sequences on the same To test the hypothesis that increasing the stability of
molecule that are chemically and structurally very similar the DNA recognition helix of MyoD enhances its DNA
to the specific substrate [1]. This sequence discrimina- binding specificity, a hybrid protein, apaMyoD, was de-
tion is often the basis of significant physiological differ- signed in which a sequence based on the peptide
ences. The production of the basic helix-loop-helix apamin was fused to the N terminus of the bHLH domain
(bHLH) transcription factor MyoD in a wide variety of cell of MyoD. Apamin is an 18-residue neurotoxic peptide
types, including fibroblasts and myoblasts, activates a from honeybee venom in which two turns of the
cascade of genes eventually leading to cellular differen- C-terminal  helix are stabilized through two disulfide
tiation and the production of muscle cells [2, 3], while bonds. These confer significant conformational stability
production of the bHLH protein MASH-1 promotes dif- to the peptide [17, 18, 19] and make this peptide an
ferentiation of committed neuronal precursor cells [4]. ideal template both for helix stabilization [20] and the
The physiological activities of MyoD and MASH-1 de- display of functional epitopes [21].
pend on the presence of DNA sequences containing the In this study, the apamin fold was used to stabilize
symmetrical core motif CANNTG (E box) [5], to which the basic recognition helix at the N terminus of the bHLH
bHLH proteins bind as homodimers (Figure 1B) or het- domain of MyoD. Molecular modeling was undertaken
erodimers with the E12 and E47 proteins [6, 7, 8]. to carefully design the hybrid. This modeling took as a
In stark contrast to their high physiological specifici- starting point the X-ray structure of the bHLH domain
ties, MASH-1 and MyoD display only limited DNA bind- of MyoD complexed to DNA [22] (Figure 1B) and a model
ing specificity in vitro [9, 10]. Electrophoretic mobility based on a recent NMR study of apamin (Figure 1C) [19,
23, 24]. Previous studies had indicated that the eight
N-terminal amino acids and cysteines 11 and 15 were*Correspondence: r.k.allemann@bham.ac.uk
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Figure 1. Design of ApaMyoD from Apamin
and MyoD-bHLH
(A) Sequence alignment of the bHLH domain
from MyoD, apamin, and the resultant fusion
protein apaMyoD.
(B) Structure of the bHLH domain of MyoD
bound as a dimer (red) to cognate DNA (gray/
blue van der Waals spheres) [22].  helices
are represented by cylinders, with tubes
marking nonhelical parts of the structure.
(C) Structure of the bee venom peptide
apamin from NMR studies [20, 23, 24]. Atoms
forming the disulfide bonds that stabilize the
structure are shown in a yellow stick repre-
sentation, with the rest of the structure
marked as a green ribbon.
(D and E) The expected architecture of apa-
MyoD when bound to DNA. The parts of the
hybrid derived from MyoD are marked in red
or blue, whereas apamin-derived peptide
segments are marked in green or yellow. The
single residue not drawn from a parent se-
quence, A107, is marked in black. The side
chain of the important nucleobase-con-
tacting residue R111 is shown as a blue stick
model. A close-up view of the end of a single
chain of the hybrid (E) shows that the apamin
extension points away from the DNA while
holding the conformation of the N-terminal
part of the basic DNA recognition helix.
necessary for the correct folding of apamin-based hy- any interference of the side chain with R111. It can be
noted that the hybrid apamin-based peptides with anbrids, while the other residues within the -helical sec-
tion at the C terminus could be varied widely [20]. Ac- alanine at this position were found to have three-dimen-
sional structures essentially identical to native apamincordingly, a number of possible hybrids of the two
structures were considered by using least squares fitting [20]. Furthermore, it is known that mutation of leucine
10 in apamin to alanine does not effect the neurotoxicityof the -helical parts from each structure with the Sybyl
6.7 package. An important consideration was that no [25] of the peptide, once again indicating that the struc-
ture is not affected by such a change.change should be made to any amino acid residue from
MyoD that had been shown to directly contact DNA in The design process and the molecular model for Apa-
MyoD in complex with its cognate DNA (Figure 1B) indi-the X-ray complex structure [22]. Furthermore, hybrids
in which the apamin extension approached the DNA cated that the hybrid protein should adopt a similar DNA
binding conformation to the natural protein. What canduplex were also precluded. These considerations re-
sulted in the hybrid apaMyoD, whose sequence is shown be expected for the conformation of ApaMyoD prior to
DNA binding? As noted above, bHLH proteins are foundin Figure 1A. A molecular model of the hybrid showed
that the apamin fold was placed over the end of the largely in unfolded conformations in the absence of DNA
[9, 11]. It can be expected that the 8 residues foundbasic helix from MyoD (Figures 1D and 1E). To ensure
that the stabilizing effect of the apamin extension was to have a helical conformation in apamin (TAxCxxxC)
[19] would also be in a helical conformation in the hybrid.in close proximity to the DNA binding region of MyoD,
the solvent-exposed residue K112 was replaced by cys- Furthermore, as helix formation is cooperative [26],
apamin provides an excellent nucleation point for furtherteine and 11 amino acids of apamin were spliced onto
the basic domain, N-terminal to residue 109 (Figure 1A). helix stabilization. In order to gauge the magnitude of
the effect that could be expected, we undertook calcula-The X-ray structure of a DNA complex of MyoD [22]
indicated that residue R111 made a nucleobase-specific tions with the AGADIR program for the prediction of
the helicity of isolated peptides [27] (inspired by similarcontact. The apamin extension was placed around this
position so it could serve chiefly to stabilize the basic considerations made by Wemmer and coworkers [20]).
The calculations (data not shown) indicated that priorhelix of apaMyoD.
Only one amino acid of the hybrid did not derive from to DNA binding the apamin extension has the potential to
stabilize up to a further two turns of helix in addition toeither the sequence of MyoD or apamin: residue 107,
which would naturally be a leucine (number 10) in apamin those directly contributed by apamin.
(Figure 1A). The molecular model of apaMyoD (Figure
1E) indicated that this position would be solvent ex- Synthesis and Structural Characterization
of ApaMyoDposed in the hybrid and would be positioned close to
the important DNA base contacting residue R111 [22]. ApaMyoD was produced in E. coli and purified ac-
cording to a procedure established previously for theThis residue was therefore changed to alanine both to
remove an exposed hydrophobic residue and to prevent bHLH domains of MASH-1 and MyoD [9, 10]. ApaMyoD
Intramolecular Control of DNA Binding Specificity
71
Figure 2. Expression and Purification of the Hybrid ApaMyoD
(A) Expression and purification of apaMyoD visualized by SDS-
PAGE. Lane 1, molecular weight markers; lane 2, protein extract
from BL21(DE3) cells containing the apaMyoD expression plasmid
before induction of expression by IPTG; lane 3, protein extract 3 hr
after induction; lane 4, pooled apaMyoD containing fractions after
CM chromatography; lane 5, purified apaMyoD after FPL chroma-
tography on Resource-S cation exchange resin.
(B) Base sequences of double-stranded oligonucleotides containing
cognate (MCK-S) and noncognate (NOE box) binding sites.
was isolated successfully by cation exchange chroma-
tography through elution with a shallow gradient of NaCl
and was essentially pure as judged by SDS-polyacryl-
amide gel electrophoresis (Figure 2A). Mass spectrome- Figure 3. Structural Characterization of ApaMyoD by CD Spec-
try and titration with Ellman’s reagent indicated that troscopy
purified apaMyoD was in its oxidized, monomeric form (A) CD spectra of MyoD-bHLH (red), oxidized apaMyoD (black), and
(data not shown). reduced apaMyoD (green) in the absence of DNA. Protein concentra-
tions were 1 M for all experiments.CD spectroscopy had revealed previously that the
(B) Effects of increasing concentrations of cognate DNA (MCK-S)bHLH domain of MyoD was largely unfolded at concen-
on the CD spectrum of apaMyoD. CD spectra of apaMyoD (1 M)trations below 5 M [9]. The mean residue ellipticity at
with 0 M (black), with 0.1 M (red), with 0.3 M MCK-S (green),
222 nm, []r,222 was determined as 3.25 (0.3)  103 with 0.5 M (yellow), and with 0.8 M MCK-S (blue) are shown.
deg cm2 dmol1 for MyoD-bHLH (1 M), which corre- (C) Temperature dependence of the mean residue ellipticity, []r, at
sponded to an -helical content of approximately 7% 222 nm of 4 M apaMyoD (black) and MyoD-bHLH (red) bound to
cognate DNA ([MCK-S]  2 M).or four amino acid residues (Figure 3A). At the same
concentration, the CD spectrum of apaMyoD showed
minima at 208 nm and 222 nm, typical of proteins with
ApaMyoD could be fully reduced with tris(2-carboxy--helical content (Figure 3A) [28]. The value of 9.17
ethyl) phosphine (TCEP). This was demonstrated with(0.6)  103 deg cm2 dmol1 measured for []r,222 indi-
Ellman’s reagent. The CD spectrum of the reduced formcated that approximately 27% of apaMyoD or 19 amino
of apaMyoD was similar to that of its parent proteinacid residues were in an -helical conformation. This
MyoD-bHLH (Figure 3A), indicating that the stabilizationvalue was slightly higher than would have been expected
of the secondary structure of apaMyoD was a directfrom the addition of a disulfide-stabilized apamin-like
result of the formation of the disulfide bridges.segment containing approximately two -helical turns.
The apamin helix most likely served as a nucleus for a
helix that extended for a further ten residues; the whole Structural Characterization of the DNA
Complexes of ApaMyoD by CD Spectroscopyof the basic DNA recognition helix was apparently held
in a predominately helical formation by the apamin ex- CD spectroscopy was also used to analyze the forma-
tion of complexes between apaMyoD and DNA. Thetension.
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addition of the MCK-S oligonucleotide comprising 17
base pairs of the IgH enhancer-like element of the mus-
cle-specific creatine kinase enhancer [29] with the cen-
tral E-box sequence CAGGTG (Figure 2B) to apaMyoD
(1 M) in its oxidized form induced a change in the CD
spectra indicative of a transition from a partially unfolded
to a mainly -helical conformation. A similar transition
had been observed previously with the bHLH domain
of MyoD [10] and with MASH-bHLH [9]. The change in
the CD spectrum was saturable, in that the addition
of excess oligonucleotide (0.8 M MCK-S and 1 M
apaMyoD monomer, equivalent to 0.5 M dimer) did not
result in a further change of the spectrum relative to a
1:1 stoichiometry (0.5 M apaMyoD dimer: 0.5 M DNA
duplex). The transition of the conformation of apaMyoD
was not dependent on the DNA sequence, as demon-
strated in experiments with the noncognate oligonucleo-
tide, NOE box (data not shown).
Heat denaturation of the DNA complexes of oxidized
apaMyoD was monitored through changes in the CD
signal at 222 nm. The DNA complexes of oxidized apa-
MyoD with both MCK-S and the NOE box oligonucleo-
tide underwent a cooperative unfolding reaction with a
midpoint of 50C, which is 13C higher than the melting
temperature observed for the DNA complexes of the
bHLH domain of MyoD (Figure 3C), indicating that the
addition of the apamin extension conferred significant
additional stability to the DNA complexes of MyoD.
DNA Binding Specificity Measured
by Fluorescence Anisotropy
The DNA binding properties of the bHLH domain of
MyoD had been studied previously by electrophoretic
mobility shift assays (EMSA), which revealed an almost Figure 4. Characterization of DNA Binding by ApaMyoD Measured
by Fluorescence Anisotropycomplete lack of sequence specificity [10]. The thermo-
Fraction, φ, of bound DNA in the complexes of (A) MyoD-bHLH, (B)dynamically rigorous technique of fluorescence anisot-
oxidized apaMyoD, and (C) reduced apaMyoD versus the concentra-ropy [30–32] is premised on the differences in size, and
tion of the free protein. The binding curves for complexes with 1hence the differences in the rates of rotational and fluo-
nM solutions of cognate (MCK-S) and noncognate DNA (NOE box)rescence anisotropies, of the free oligonucleotide la-
are indicated in black and red, respectively.
beled with a fluorescent tag and its protein complex.
It therefore allows the determination of the apparent
dissociation constants of protein-DNA complexes under The specificity of DNA binding by apaMyoD was sig-
nificantly increased compared to that of MyoD-bHLH.true equilibrium conditions. Typical results from such
fluorescence polarization experiments are shown in Fig- The concentration of oxidized apaMyoD needed to bind
50% of MCK-S was approximately four times smallerure 4. The addition of protein to a solution of fluores-
cently labeled double-stranded oligonucleotide resulted than that of MyoD-bHLH with a dissociation constant
of 4.1 (0.5)  1017 M2 (Table 1). The presence of thein a saturable increase in the fluorescence anisotropy,
indicating that the protein was bound to the DNA in apamin extension clearly increased the affinity of apa-
MyoD for specific, E-box-containing DNA. Control ex-solution. In agreement with the results from EMSA ex-
periments [10], MyoD-bHLH showed similar affinities for periments with apamin exhibited no change in fluores-
cence anisotropy over the whole range of peptideMCK-S and the heterologous DNA sequence NOE box
(Figure 4A). The NOE-box oligonucleotide has the same concentrations studied with MyoD-bHLH and apaMyoD,
indicating that apamin itself had DNA binding affinitybase composition as MCK-S but with a scrambled se-
quence, and it does not contain an E-box sequence. significantly lower than apaMyoD. The increased DNA
binding affinity of oxidized apaMyoD was dependent onThe bHLH proteins MASH-1 and MyoD have been shown
previously to bind to NOE-box DNA with significantly the presence of the disulfides; when the disulfides were
reduced with TCEP, the dissociation constant of thereduced affinity relative to MCK-S [9–12]. The KD values
for MyoD-bHLH binding to MCK-S and NOE box were complex of MCK-S with reduced apaMyoD was 4.0
(0.2)  1016 M2 (Table 1). Interestingly, even in itsdetermined as 8.0 (0.4)  1016 M2 and 9.0 (0.8) 
1016 M2, respectively, resulting in an energetic differ- reduced form apaMyoD bound cognate DNA slightly
better than MyoD-bHLH, possibly due to residual struc-ence at 25C between the stability of the two complexes
of only 70 cal mol1 (Table 1). ture of the apamin extension even in the absence of
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the disulfide bonds [24]. The small increase in the DNA
binding affinity of the reduced form of apaMyoD may
have resulted from the short extension of the basic helix
at its N terminus through the introduction of the apamin
residues.
The affinity of oxidized apaMyoD for the noncognate
NOE box DNA was increased to a much smaller extent
by the apamin extension [KD  4.5 (0.4)  1016 M2]
than had been observed for MCK-S (Table 1). Overall,
the introduction of the disulfide linkage between apamin
and the basic region of MyoD-bHLH led to a significantly
increased stability of the complexes of apaMyoD with
specific DNA and an increase in the DNA binding speci-
ficity of one order of magnitude. The specificity dis-
played by reduced apaMyoD was increased less than
2-fold relative to MyoD-bHLH (Table 1).
Discussion
The DNA binding regions of eukaryotic transcription fac-
tors are often not part of a globular fold, but isolated
elements of secondary structure. The members of the
basic-zipper (BZ), the bHLH, and the bHLH-zipper fami-
lies all interact with the major groove of DNA through
an  helix [33, 34], large parts of which are solvent
exposed even in the complexes. These recognition heli-
ces adopt well-defined structures only upon binding to
DNA; in their unliganded forms they show significant
conformational flexibility. Proteins that rely on BZ,
bHLH, or bHLH-zipper elements for DNA binding nor-
mally display only limited sequence specificity in vitro.
The DNA binding specificities of prokaryotic transcrip-
tional regulators, on the other hand, are generally high.
Their recognition elements are normally part of a com-
pact DNA binding domain. The recognition helix of the
prokaryotic helix-turn-helix (HTH) motif, for instance, is
stabilized through interactions with other parts of the
protein [35, 36]; indeed, the HTH motif adopts a stable
conformation only in the structural context of the whole
protein [37, 38]. A correlation between the extent of DNA
binding specificity of a protein and the conformational
rigidity of its DNA recognition element has been pro-
posed previously [39]. Shepartz and coworkers grafted
residues from the DNA recognition helix of the engrailed
homeodomain onto the helix of avian pancreatic poly-
peptide [40]. The achieved structural preorganization
compensated thereby for the reduction of the free en-
ergy of binding as a result of the reduced number of
protein-DNA contacts relative to the DNA complex of
the parent homeodomain.
The low DNA binding specificities of many eukaryotic
transcription factors are in sharp contrast to their exqui-
site physiological specificities. The bHLH protein MyoD,
for instance, has been called the master regulator of
muscular differentiation because its expression induces
the differentiation of many cell types into myotubes
[41, 42]. Transcriptional regulation in eukaryotes relies
largely on multiprotein complexes with the potential for
combinatorial interactions that can change the confor-
mational flexibilities of DNA recognition elements, lead-
ing to variations in the DNA binding specificities.
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As a model for such interactions of the recognition
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helix of MyoD with other components of the transcrip- ity. Such a mechanism could help to resolve the discrep-
ancy between the low DNA binding specificity of MyoDtional machinery, we have produced apaMyoD, in which
a N-terminal extension to the basic region of MyoD stabi- in vitro and its exquisite physiological specificity. A simi-
lar mechanism has been proposed for the activation bylized the  helix through two disulfide bonds. ApaMyoD
bound to E-box-containing DNA sequences more avidly human T cell leukaemia virus type I Tax protein of many
cellular transcription factors that depend on a BZ do-than its parent protein MyoD-bHLH (Table 1). bHLH pro-
teins are known to undergo a conformational change main for DNA recognition [46, 47]. Tax alters the relative
affinity of basic-zipper proteins for different DNA bindingon DNA binding from a largely unfolded to a mainly
-helical structure [9]. The basic region is unfolded even sites through direct interaction with their basic domains,
thereby increasing the stability of the dimeric forms ofat concentrations where the protein is mainly dimeric
and the HLH-region stably folded [12]. On DNA binding, BZ proteins [48, 49]. Similarly, the hepatitis B virus pro-
tein pX has been shown to increase the stability of thethe conformation of these residues becomes helical too,
and previous work for the DNA binding reaction of DNA complexes of BZ proteins in a sequence-depen-
dent manner [50]. Thus, Tax and pX increase the DNAMASH-1 indicated that a significant entropic penalty
resulted from this folding transition [12]. CD spectros- binding affinity and specificity of BZ proteins through a
mechanism similar to that of apaMyoD.copy had indicated that approximately 27% of apaMyoD
was in an -helical conformation at DNA binding con- The work described in this paper represents the first
example of a designed transcription factor that bindscentrations, while only 7% of those of MyoD-bHLH were
helical. The increased DNA binding affinity of apaMyoD to DNA with significantly increased DNA binding affinity
and specificity as a consequence of disulfide-depen-relative to MyoD-bHLH was most likely the result of the
increased proportion of -helical structure within the dent intramolecular stabilization of the DNA recognition
helix. Our results provide a possible resolution of therecognition helix, leading to a reduction of the number
of residues undergoing a conformational change during mechanistic paradox between the impressive physio-
logical specificity displayed by bHLH proteins and theirDNA binding.
The stability of the DNA complexes of apaMyoD to modest DNA binding specificity in vitro.
thermal denaturation was also significantly increased.
For MyoD-bHLH, an unfolding transition was observed
Significanceat 37C in thermal denaturation experiments. For the
DNA complexes of apaMyoD, on the other hand, this
In sharp contrast to many prokaryotic transcriptiontransition occurred at 50C. The unfolding of apaMyoD
factors, eukaryotic transcriptional regulators oftenabove this temperature was most likely due to the lack
display only limited sequence specificity in vitro dueof stability of the complex rather than a consequence
to their relatively simple structures and the high con-of the thermally induced melting of the oligonucleotide,
formational flexibilities of their DNA binding motifs.which occurs with a midpoint of 61C [12].
The significant stabilization of the DNA recognitionInterestingly, the affinity of apaMyoD for heterologous
helix of the basic helix-loop-helix protein MyoD thatDNA sequences was increased only approximately
resulted from the intramolecular interaction with an2-fold. Limiting the number of accessible conformations
N-terminally fused apamin-like peptide led to a redox-of the recognition helix of apaMyoD appeared to stabi-
state-dependent increase in the affinity of the bHLHlize the interaction with specific DNA and destabilize the
motif for its natural DNA target sites. As a conse-complex with nonspecific DNA, leading to a significant
quence, the specificity of DNA binding also increased.increase in the DNA binding specificity of the hybrid
The fusion protein between MyoD and apamin pro-protein. This enhanced specificity was clearly a conse-
vided a model for the modulation of the DNA bindingquence of the disulfide-stabilized intramolecular inter-
properties of proteins like MyoD by intermolecular in-actions, as the reduced form of apaMyoD displayed
teraction with other members of the transcriptionspecificity similar to that of MyoD-bHLH (Table 1). Local
complex. Because the stabilization of the basic regionstabilization of the DNA binding domain the tryptophan
of MyoD is achieved mainly through the formation ofrepressor of E. coli [43] has been shown to lead to a
two disulfide bonds, the properties of the fusion pro-reduction of the conformational flexibility and increased
tein could be controlled through changes in the redoxspecificity. Amino acid substitutions that stabilized the
conditions. Many other biologically important pro-DNA binding domain of the repressor locally led to a
cesses that rely on the interaction with key helicalreduction of the conformational flexibility [44] and an
domains might be reversibly controlled in a similarincrease in the DNA binding specificity through reduced
fashion.affinity for nonspecific DNA [45].
The intramolecular interactions between the N-ter-
minal apamin-like extension and the basic region in apa- Experimental Procedures
MyoD can be seen as a model for the modulation of
Materialsthe DNA binding properties of transcriptional regulators
All reagents were from Sigma and Invitrogen unless indicated other-through intermolecular interaction between their DNA
wise. Oligonucleotides were purchased from Alta-Biosciences, Uni-recognition elements and other components of the tran-
versity of Birmingham. Sequences of oligonucleotides used arescription complex such as the members of the MEF-2
shown in Figure 2B. Complementary single-stranded oligonucleo-
family. MEF-2C, a potent coregulator of MyoD, could tides were annealed by heat denaturation followed by slow cooling
stabilize a specific conformation of the basic region of to room temperature. Oligonucleotides used for fluorescence mea-
surements were 3
 labeled with acetamido-5-fluorescein and subse-MyoD, thereby altering its intrinsic DNA binding specific-
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quently annealed to their complementary unlabeled oligonucleotide FPLC on a Resource-S (Pharmacia) ion-exchange column as de-
scribed [9]. The collected fractions containing apaMyoD wereas described previously [12].
pooled and concentrated by ultrafiltration using an Amicon YM-3
filter. The buffer was exchanged to 5 mM sodium acetate (pH 5.0)Molecular Modeling
by dialysis. SDS-PAGE showed a single protein band (Figure 2A).Modeling was performed using the Sybyl 6.7 program (Tripos) run-
Titration with Ellman’s reagent showed that apaMyoD had oxidizedning on a Silicon Graphics Octane workstation. The 2.8 A˚ X-ray
during the final dialysis step [55]. MALDI-TOF mass spectrometrystructure of the bHLH domain of MyoD complexed to cognate DNA
revealed a mass of 8052.0, which corresponded well with the calcu-[22] was obtained from the Protein Data Bank (ID code 1mdy). Coor-
lated mass of 8050.5 for the oxidized monomer of apaMyoD withoutdinates for apamin were based on a recent NMR structure [23]. This
the N-terminal Met. Protein concentrations were determined usingwas adjusted to incorporate likely interactions for Thr 9 [19] and
the microtannin assay [56]. The yields for the preparation were ap-Asn 2 [24]. Furthermore, the conformations of the last three residues
proximately 0.5 mg of purified protein/l culture. Reduced apaMyoDthat tend to be disordered in apamin were set to ideal -helical.
was prepared from the oxidized form by reduction with TCEP. AMolecular graphics visualization of the two parent structures was
solution of apaMyoD (5 M) was treated with TCEP (2.5 mM) to giveused to decide upon the sequence of the hybrid protein. The two
a fully reduced sample as judged by CD and Ellman’s reagent.structures were superimposed using least squares fitting to overlay
the main chain atoms of -helical parts. Once a sequence had been
chosen (Figure 1A), a model for the hybrid protein was constructed CD Spectroscopy
(Figure 1). This involved using least squares fitting to place the main Spectra were all measured at 20C (unless otherwise indicated)
chain of residues A12 to H18 from apamin over corresponding atoms using a Jasco J810 spectropolarimeter. The concentrations of
from MyoD residues D109 to T115. The extension to the structure MyoD-bHLH and apaMyoD were 1 M in 5 mM Tris-HCl (pH 7).
drawn from apamin was then merged with the MyoD molecule, For thermal denaturation studies, the protein concentration was
and residues 108 and 112 were altered to cystine within the Sybyl increased to 4 M, and the sample was heated from 5C to 90C at
program. The modified residues were then subjected to local energy a rate of 0.5C min1. The CD results are reported as mean residue
minimization to regularize bond lengths and angles using the conju- ellipticities []r, which was calculated from the observed ellipticity,
gate gradients protocol and an AMBER potential energy function , measured in mdeg according to the following equation:
[51] within Sybyl. The resultant model is conceptual, demonstrating
[]r  /10 (n-1) c l,that the apamin extension of the hybrid can be accommodated
without disrupting any DNA-recognition interactions found for the
where c is the concentration of the peptide in mol l1, n is the numbernative bHLH domain of MyoD (Figure 1E). Molecular graphics images
of amino acids in the peptide, and l is the path length in cm. Valueswere produced using the VMD program [52].
reported for mean residue ellipticities are the average of at least
three independent measurements.Expression of MyoD-bHLH and ApaMyoD
A cDNA for apaMyoD was constructed in the plasmid pJGetMyoD-
Fluorescence AnisotropybHLH that had been used previously for the production of the bHLH
Fluorescence anisotropy measurements were made at 25C on adomain of MyoD [10]. pJGetMyoD-bHLH contains the cDNA for the
Perkin Elmer Luminescence Spectrometer LS50B arranged in L for-bHLH domain of MyoD within plasmid pJGetita [10], a derivative
mat (494 nm excitation, 525 nm emission). Titrations were performedof pET3a [53], thereby allowing high-level expression from the T7
in 0.5 ml quartz cuvettes. The assay buffer was 5 mM Tris-HCl (pHpromoter in BL21(DE3) cells. The 5
 extension coding for the apamin
7.9), 150 mM NaCl, 6 mM MgCl2, and 10% glycerol. Defined volumesaddition (Figure 1) was inserted upstream of the basic region of
(0.5–2 l) from a stock solution of the protein (2.5-10 M) wereMyoD-bHLH by PCR using the following primers: A (5
-GTCCATAT
added successively to 1 nM solutions of the fluorescently labeledGTGCAACTGCAAAGCTCCCGAGACCGCTGCTTGCGCTGATCGCC
double-stranded oligonucleotide (3
 labeled with acetamido-5-fluo-GCAAGGCC-3
) and B (5
-AGCGGATCCTCATCAGTCGCGCAGC
rescein) in a total volume of 1 ml. The G factor (ratio of sensitivitiesAGCTGCAG-3
). Following digestion with NdeI and BamHI, the PCR
of the monochromator for horizontally and vertically polarized light)product was inserted into pJGetita. The codon for Lys112 was sub-
was calculated for each measurement using the following equationsequently replaced with the codon for Cys by PCR using the follow-
[57]:ing primers: C, (5
-GATATACATATGTGCAACTGCAAAGCTCCC-3
);
D, (5
-CCTGCGCTGATCGCCGCTGCGCCGCCACCATG-3
); E, (5
-
G  I⊥/I||, (1)CATGGTGGCGGCGCAGCGGCGATCAGCGCAAG-3
); and F, (5
-AGC
GGATCCTCATCAGTCGCGCAGCAGCTGCAG-3
). Altered nucleo- where I|| and I⊥ are the intensities of the fluorescent emissions in
tides are underlined. The DNA sequence was verified using the parallel and perpendicular planes, respectively, to the excitation
dideoxy sequencing method [54]. BL21(DE3) cells containing the plane. The G factor values ranged from 0.99–1.06. Values for fluores-
apaMyoD expression plasmid were grown at 37C in LB media con- cence anisotropy (A) were then determined from the following equa-
taining 100 g ml1 ampicillin until the OD600 reached 0.5. IPTG was tion [58]:
added to a final concentration of 1 mM, and the cells were harvested
after 3 hr by centrifugation. A  (I||  GI⊥)/(I||  2GI⊥). (2)
For each anisotropy value, ten measurements were taken and aver-Protein Purification
aged using an integration time of 5 s.MyoD-bHLH was purified as described previously [10]. ApaMyoD
Fluorescence data were expressed (see Figure 4) aswas purified essentially as described for the purification of the bHLH
domain of MASH-1 [9]. In short, the cells were resuspended in 3 ml
φ  (A-AD)/(APD-AD), (3)of water/g of wet cells, and 1 mM phenylmethanesulfonyl fluoride
was added. Following the addition of 2 volumes of lysis buffer (100 where A denotes the fluorescence anisotropy in the presence of
mM ammonium acetate [pH 6.7], 100 mM sodium chloride, 100 mM the indicated concentration of protein, AD denotes the fluorescence
2-mercaptoethanol), the cells were sonicated for 10 min on ice. The anisotropy of the solution containing the fluorescently labeled DNA
resulting suspension was dialyzed at ambient temperature twice and no protein, and APD denotes the fluorescence anisotropy at
against urea buffer (5 mM sodium acetate [pH 5.0], 100 mM saturation [32, 58]. As previously described [9, 59], these data were
2-mercaptoethanol, 8 M urea). The dialysate was centrifuged and fit using Sigma Plot to the Langmuir isotherm for cooperative two-
the supernatant was applied to a column containing 30 ml of Bio- state binding of two protein monomers to one DNA duplex:
Gel CM ion-exchange resin (Bio Rad) preequilibrated with urea
buffer. The loaded resin was washed extensively with urea buffer, φFit  1/(1  KD2/[P]2). (4)
and the protein was eluted with one column volume of urea buffer
containing 1 M sodium chloride. The eluate was dialyzed twice [P] is the concentration of monomeric protein, and KD is the dissocia-
tion constant. These fits yielded the apparent dissociation constantagainst urea buffer. The protein was further purified by preparative
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KD, from which the concentration of protein, [P]1/2, where half-maxi- the neurotoxin apamin from the venom of the honeybee Apis
mellifica. Bioorganicheskaya Khimiya 4, 1022–1028.mal DNA binding occurs, was calculated as [P]1/2   KD.
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